Linong Ji

发表

Cardiovascular benefits beyond urinary glucose excretion: A hypothesis generated from two meta‐analyses

Chu Lin, Xiaoling Cai, J. Linong, 2021, Diabetes, obesity & metabolism.

Differential effect of interventions in patients with prediabetes stratified by a machine learning‐based diabetes progression prediction model

Yingying Luo, Xiu-ying Zhang, Xianghai Zhou, 2023, Diabetes, obesity & metabolism.

Efficacy and safety of tirzepatide in people with type 2 diabetes by baseline body mass index: An exploratory subgroup analysis of SURPASS-AP-Combo.

Liying Du, Rui Wang, Jianhua Ma, 2024, Diabetes, obesity & metabolism.

CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

H. Rodbard, T. Battelino, P. Topsever, 2024, Cardiovascular diabetology.

Maternal isolated hypothyroxinemia in the first trimester is not associated with adverse pregnancy outcomes, except for macrosomia: a prospective cohort study in China

Xiaomei Zhang, N. Yuan, Jianbin Sun, 2023, Frontiers in endocrinology.

Plasma proteome profiling reveals the therapeutic effects of the PPAR pan-agonist chiglitazar on insulin sensitivity, lipid metabolism, and inflammation in type 2 diabetes

Junjie Hou, Hongyang Liu, Weiping Jia, 2024, Scientific reports.

Review: Machine learning in precision pharmacotherapy of type 2 diabetes—A promising future or a glimpse of hope?

Xiantong Zou, Linong Ji, Yingning Liu, 2023, Digital health.

Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases - Recommendations from the taskforce of the guideline workshop.

H. Rodbard, P. Topsever, Per Olav Vandvik, 2024, Diabetes research and clinical practice.

Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial.

Yiming Li, R. Agesen, Jianlin Geng, 2024, Diabetologia.

Association between frequency of self-monitoring of blood glucose and glycemic control in patients with type 2 diabetes.

Xianghai Zhou, Linong Ji, Xiaoyan Sun, 2023, Diabetes research and clinical practice.

Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once‐weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1‐5, 7‐10 and SUSTAIN China

H. Rodbard, A. Ahmann, I. Lingvay, 2023, Diabetes, obesity & metabolism.